Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

about

Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy.

P2860

Q51736041-FDD024DC-143A-49F4-AE30-2942F25AE7A6

P2860

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

Item

http://www.wikidata.org/entity/Q38819166

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

@en

type

Item

label

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

@en

prefLabel

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

@en

P1476

Present and future roles of FDG-PET/CT imaging in the management of lung cancer

@en

P2093

Hayato Kaida

http://www.w3.org/2001/XMLSchema#string

Hiroshi Doi

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Kitajima

http://www.w3.org/2001/XMLSchema#string

Kozo Kuribayashi

http://www.w3.org/2001/XMLSchema#string

Tetsuya Tsujikawa

http://www.w3.org/2001/XMLSchema#string

Tomonori Kanda

http://www.w3.org/2001/XMLSchema#string

Yukihisa Tamaki

http://www.w3.org/2001/XMLSchema#string

P2860

Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis

Cancer treatment and survivorship statistics, 2014

Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

P2888

s11604-016-0546-2

P304

387-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11604-016-0546-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomohiko Yamane

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051881926

http://www.w3.org/2001/XMLSchema#string

P698

27121156

http://www.w3.org/2001/XMLSchema#string

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

about

P2860

P2860

Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698